Group 1 - The company plans to issue shares and pay cash to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. and raise supporting funds, which is referred to as "this transaction" [1] - To ensure fair information disclosure and protect investor interests, the company has applied for a stock suspension starting from May 22, 2025 [1] - The cumulative price change of the company's stock in the 20 trading days prior to the suspension was 12.27% after excluding the impact of the broader market index (399006.SZ) and 14.01% after excluding the impact of the industry index (801150.SL) [1] Group 2 - The stock price did not experience abnormal fluctuations, as the cumulative price change did not exceed 20% in the 20 trading days before the suspension [1]
迈普医学: 关于本次交易信息发布前公司股票价格波动情况的说明